SEARCH

SEARCH BY CITATION

References

  • Appay, V., Zaunders, J.J., Papagno, L., Sutton, J., Jaramillo, A., Waters, A., Easterbrook, P., Grey, P., Smith, D., McMichael, A.J., Cooper, D.A., Rowland-Jones, S.L. & Kelleher, A.D. (2002) Characterization of CD4+ CTLs ex vivo. The Journal of Immunology, 168, 59545958.
  • Arpinati, M., Green, C.L., Heimfeld, S., Heuser, J.E. & Anasetti, C. (2000) Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood, 95, 24842490.
  • Brines, R.D. & Klaus, G.G. (1993) Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand. International Immunology, 5, 14451450.
  • Chakrabarti, S., Mackinnon, S., Chopra, R., Kottaridis, P.D., Peggs, K., O'Gorman, P., Chakraverty, R., Marshall, T., Osman, H., Mahendra, P., Craddock, C., Waldmann, H., Hale, G., Fegan, C.D., Yong, K., Goldstone, A.H., Linch, D.C. & Milligan, D.W. (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood, 99, 43574363.
  • Chattopadhyay, P.K., Yu, J. & Roederer, M. (2005) A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nature Medicine, 11, 11131117.
  • Cobbold, M., Khan, N., Pourgheysari, B., Tauro, S., McDonald, D., Osman, H., Assenmacher, M., Billingham, L., Steward, C., Crawley, C., Olavarria, E., Goldman, J., Chakraverty, R., Mahendra, P., Craddock, C. & Moss, P.A. (2005) Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. Journal of Experimental Medicine, 202, 379386.
  • Einsele, H., Ehninger, G., Hebart, H., Wittkowski, K.M., Schuler, U., Jahn, G., Mackes, P., Herter, M., Klingebiel, T., Loffler, J., Wagner, S. & Muller, C.A. (1995) Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood, 86, 28152820.
  • Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Loffler, J., Grigoleit, U., Moris, A., Rammensee, H.G., Kanz, L., Kleihauer, A., Frank, F., Jahn, G. & Hebart, H. (2002) Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood, 99, 39163922.
  • Frentsch, M., Arbach, O., Kirchhoff, D., Moewes, B., Worm, M., Rothe, M., Scheffold, A. & Thiel, A. (2005) Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nature Medicine, 11, 11181124.
  • Gallot, G., Vivien, R., Ibisch, C., Lule, J., Davrinche, C., Gaschet, J. & Vie, H. (2001) Purification of Ag-specific T lymphocytes after direct peripheral blood mononuclear cell stimulation followed by CD25 selection. I. Application to CD4+ or CD8+ cytomegalovirus phosphoprotein pp65 epitope determination. The Journal of Immunology, 167, 41964206.
  • Goodrich, J.M., Bowden, R.A., Fisher, L., Keller, C., Schoch, G. & Meyers, J.D. (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Annals of Internal Medicine, 118, 173178.
  • Gooley, T.A., Chien, J.W., Pergam, S.A., Hingorani, S., Sorror, M.L., Boeckh, M., Martin, P.J., Sandmaier, B.M., Marr, K.A., Appelbaum, F.R., Storb, R. & McDonald, G.B. (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. New England Journal of Medicine, 363, 20912101.
  • Gratama, J.W., Brooimans, R.A., van der Holt, B., Sintnicolaas, K., van Doornum, G., Niesters, H.G., Lowenberg, B. & Cornelissen, J.J. (2008) Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Cytometry Part B: Clinical Cytometry, 74, 211220.
  • Hartung, T., Doecke, W.D., Bundschuh, D., Foote, M.A., Gantner, F., Hermann, C., Lenz, A., Milwee, S., Rich, B., Simon, B., Volk, H.D., von Aulock, S. & Wendel, A. (1999) Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clinical Pharmacology and Therapeutics, 66, 415424.
  • Khanna, N., Stuehler, C., Conrad, B., Lurati, S., Krappmann, S., Einsele, H., Berges, C. & Topp, M.S. (2011) Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood, 118, 11211131.
  • Leen, A.M., Myers, G.D., Sili, U., Huls, M.H., Weiss, H., Leung, K.S., Carrum, G., Krance, R.A., Chang, C.C., Molldrem, J.J., Gee, A.P., Brenner, M.K., Heslop, H.E., Rooney, C.M. & Bollard, C.M. (2006) Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nature Medicine, 12, 11601166.
  • Levine, J.E., Braun, T., Penza, S.L., Beatty, P., Cornetta, K., Martino, R., Drobyski, W.R., Barrett, A.J., Porter, D.L., Giralt, S., Leis, J., Holmes, H.E., Johnson, M., Horowitz, M. & Collins, Jr, R.H. (2002) Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. Journal of Clinical Oncology, 20, 405412.
  • Lugthart, G., Albon, S.J., Ricciardelli, I., Kester, M.G., Meij, P., Lankester, A.C. & Amrolia, P.J. (2012) Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy. Journal of Immunotherapy, 35, 4253.
  • Mackinnon, S., Thomson, K., Verfuerth, S., Peggs, K. & Lowdell, M. (2008) Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. Blood Cells, Molecules, and Diseases, 40, 6367.
  • Micklethwaite, K., Hansen, A., Foster, A., Snape, E., Antonenas, V., Sartor, M., Shaw, P., Bradstock, K. & Gottlieb, D. (2007) Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 13, 707714.
  • Morris, E.S., MacDonald, K.P., Rowe, V., Johnson, D.H., Banovic, T., Clouston, A.D. & Hill, G.R. (2004) Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood, 103, 35733581.
  • Neri, S., Mariani, E., Meneghetti, A., Cattini, L. & Facchini, A. (2001) Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clinical Diagnostic Laboratory Immunology, 8, 11311135.
  • Otto, M., Barfield, R.C., Iyengar, R., Gatewood, J., Muller, I., Holladay, M.S., Houston, J., Leung, W. & Handgretinger, R. (2005) Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation. Journal of Immunotherapy, 28, 7378.
  • Pan, L., Teshima, T., Hill, G.R., Bungard, D., Brinson, Y.S., Reddy, V.S., Cooke, K.R. & Ferrara, J.L. (1999) Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood, 93, 40714078.
  • Peggs, K.S. (2009) Adoptive T cell immunotherapy for cytomegalovirus. Expert Opinion on Biological Therapy, 9, 725736.
  • Peggs, K.S., Verfuerth, S., Pizzey, A., Khan, N., Guiver, M., Moss, P.A. & Mackinnon, S. (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet, 362, 13751377.
  • Peggs, K.S., Thomson, K., Samuel, E., Dyer, G., Armoogum, J., Chakraverty, R., Pang, K., Mackinnon, S. & Lowdell, M.W. (2011) Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. Clinical Infectious Diseases, 52, 4957.
  • Perruccio, K., Tosti, A., Burchielli, E., Topini, F., Ruggeri, L., Carotti, A., Capanni, M., Urbani, E., Mancusi, A., Aversa, F., Martelli, M.F., Romani, L. & Velardi, A. (2005) Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood, 106, 43974406.
  • Powell, D.J., Parker, L.L. & Rosenberg, S.A. (2005) Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples. Journal of Immunotherapy, 28, 403411.
  • Reusser, P., Riddell, S.R., Meyers, J.D. & Greenberg, P.D. (1991) Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood, 78, 13731380.
  • Riddell, S.R., Watanabe, K.S., Goodrich, J.M., Li, C.R., Agha, M.E. & Greenberg, P.D. (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science, 257, 238241.
  • Rutella, S., Rumi, C., Testa, U., Sica, S., Teofili, L., Martucci, R., Peschle, C. & Leone, G. (1997) Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplantation, 20, 355364.
  • Sica, S., Rutella, S., Di, M.A., Salutari, P., Rumi, C., Ortu la, B.E., Etuk, B., Menichella, G., D'Onofrio, G. & Leone, G. (1996) rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes. Journal of Hematotherapy, 5, 391397.
  • Slezak, S.L., Bettinotti, M., Selleri, S., Adams, S., Marincola, F.M. & Stroncek, D.F. (2007) CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects. Journal of Translational Medicine, 5, 17.
  • Tayebi, H., Kuttler, F., Saas, P., Lienard, A., Petracca, B., Lapierre, V., Ferrand, C., Fest, T., Cahn, J., Blaise, D., Kuentz, M., Herve, P., Tiberghien, P. & Robinet, E. (2001) Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Experimental Hematology, 29, 458470.
  • Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D. & Riddell, S.R. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine, 333, 10381044.
  • Watanabe, K., Suzuki, S., Kamei, M., Toji, S., Kawase, T., Takahashi, T., Kuzushima, K. & Akatsuka, Y. (2008) CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy. International Journal of Hematology, 88, 311320.
  • Wehler, T.C., Karg, M., Distler, E., Konur, A., Nonn, M., Meyer, R.G., Huber, C., Hartwig, U.F. & Herr, W. (2008) Rapid identification and sorting of viable virus-reactive CD4+ and CD8+ T cells based on antigen-triggered CD137 expression. Journal of Immunological Methods, 339, 2337.
  • Wolfl, M., Kuball, J., Ho, W.Y., Nguyen, H., Manley, T.J., Bleakley, M. & Greenberg, P.D. (2007) Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood, 110, 201210.
  • Zandvliet, M.L., Falkenburg, J.H., Jedema, I., Willemze, R., Guchelaar, H.J. & Meij, P. (2009) Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapy. Journal of Immunotherapy, 32, 513523.
  • Zandvliet, M.L., van, L.E., Jedema, I., Veltrop-Duits, L.A., Willemze, R., Guchelaar, H.J., Falkenburg, J.H. & Meij, P. (2010) Co-ordinated isolation of CD8+ and CD4+ T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy. Cytotherapy, 12, 933944.